Meridian Medical Technologies announced today that it will combine with Kindeva Drug Delivery (“Kindeva”). The combination will create a leading global drug-device combination product Contract Development and Manufacturing Organization (“CDMO”). Kindeva and Meridian will continue to operate independently until closing. The combined company will have a substantial breadth of drug delivery capabilities, with expertise and technology spanning the parenteral, inhalation, transdermal, and intradermal routes of administration. Milton Boyer, CEO of Meridian, will be CEO of the newly combined company. “We are incredibly excited about the opportunities that will result from the combination of two companies with deep roots in complex drug delivery,” said Milton Boyer. “The integrated, complementary offerings of Kindeva and Meridian create a CDMO with a broad portfolio of capabilities and proprietary technology platforms across multiple drug delivery formats, enabling us to serve customers and communities across multiple large and growing end markets.”The COMET-MCM is designed to quickly and efficiently cover large underwater areas with both high-definition sonar imaging and TV camera capabilities, by offering the most accurate real- time tracking and positioning of the market. Alternatively, micro-AUVs NEMOSENS, man- portable and modular vehicle offering the same capabilities of live tracking and high accuracy positioning would operate in very shallow water (less than 5m) for various scope of operations like beaching operations, rapid environmental assessment or identification and localization of underwater mines.
Read more about this news here.
